Stay updated on Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.

Latest updates to the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.6.5 was added to the page, replacing the previous v3.6.4. This indicates a site software update and does not alter study details.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedFooter revision label updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a new page revision.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.6.3 replaces the previous Revision: v3.6.0 on the page, indicating a recent deployment/update to the page framework. It does not reflect changes to the study details or study-related content.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page adds new help/navigation items and shows recruitment status as No longer looking for participants. The intervention header changes from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision label updates from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded a new revision entry v3.5.5 to the page's revision history along with the associated dates (2026-06-02, 2027-04, 2026-05-29). Removed the previous revision entry v3.5.4 and its dates (2026-05-26, 2032-05, 2026-05-21).SummaryDifference0.1%

- Check81 days agoChange DetectedThe page shows a revision of enrollment/time-related fields: old status values such as Recruiting and Completed were removed, while new date fields with Actual/Estimated labels (including 2026-05-26, 2026-05-21, 2026-05, 2032-05) were added to reflect updated timelines.SummaryDifference4%

Stay in the know with updates to Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.